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10.Guidelines to evaluate patients for coronary artery disease (CAD) during preoperative evalu-
ation for orthotopic liver transplantation (OLT) are conflicting. Cardiac catheterization is
not without risk in patients with end-stage liver disease. No study to date has looked at the
utility of non−electrocardiogram-gated chest computed tomography (CT) in the preliver
transplant population. Our hypothesis was that coronary artery calcium scores (CACSs)
from chest CT scans ordered during the liver transplant workup can identify patients who
would benefit from invasive angiography. Nine hundred and fifty-three patients who under-
went coronary angiography as part of their OLT workup were considered. Charts were ran-
domly selected and reviewed for the presence of a chest CT performed before coronary
angiography during the OLT workup. Agatston and Weston scores were calculated. CACS
results were compared with coronary angiography findings. Nine of 54 patients were found
to have obstructive CAD by angiography. Receiver-operating characteristic analysis demon-
strated that an Agatston score of 251 and aWeston score of 6 maximized sensitivity and spec-
ificity for detection of obstructive coronary disease. An Agatston score <4 or Weston score
<2 excluded the presence of obstructive CAD; using these thresholds, 13 patients (24%) or
15 patients (28%), respectively, could have theoretically avoided catheterization without
missing significant CAD. In conclusion, our data identify the strength of CACS in ruling out
coronary disease in patients being evaluated for OLT. Calcium scoring from non−electrocar-
diogram-gated CT studies may be integrated into preoperative algorithms to rule out
obstructive CAD and help avoid invasive angiography in this high-risk population. © 2019
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1016/j.amjcard.2019.04.025Coronary artery disease (CAD) is an important consider-
ation in the preoperative evaluation of patients for orthotopic
liver transplantation (OLT).1−3 However, guidelines to evalu-
ate patients for underlying CAD during preoperative evaluationfor OLT are conflicting.4−6 Cardiac catheterization is not
without risk in end-stage liver disease (ESLD) patients,
who are often thrombocytopenic and coagulopathic.7,8 It is
for these reasons that liver transplant teams rely on nonin-
vasive stress testing before OLT.2,9,10 These tests are bur-
dened by inaccuracies.2,9 The coronary artery calcium
score (CACS) has been established as a predictor of CAD,
cardiovascular events, and all-cause mortality,11−13 and has
been incorporated into the American College of Cardiology
Foundation and American Heart Association guidelines for
evaluating low-to-intermediate-risk individuals.14,15 How-
ever, only limited data are available regarding the utility of
CACS in liver transplant patients. Studies have shown an
association between traditional CAD risk factors and
CACS in liver transplant recipients.16,17 CACSs have also
been predictive of cardiovascular complications within 1
month of liver transplant.18 Two studies have demonstrated
an association between Agatston scores from electrocardio-
gram (ECG)-gated computed tomography (CT) scans
and cardiac catheterization findings in liver transplant can-
didates.19,20 No study to date has looked at the utility of
non−ECG-gated CT scans in the preliver transplant popula-
tion, which are routinely performed to exclude pulmonary
pathology or metastatic disease. Little is known about the
prognostic significance of CACS from nongated CT,
Miscellaneous/Coronary Artery Calcium Preliver Transplant 279although limited data have suggested it correlates well with
ECG-gated studies.21−23 The aim of this study was to deter-
mine the predictive value of incidental coronary artery cal-
cium discovered on non−ECG-gated chest CT in the preliver
transplant population. Our hypothesis was that by retrospec-
tively evaluating CT scans ordered during the liver transplant
workup, it may be possible to more accurately identify
patients who would benefit from invasive angiography.Methods
Patients who underwent coronary angiography as part of
their liver transplant workup from 2006 to 2015 at a single
academic medical center were retrospectively considered.
At the time of OLT evaluation, the decision to proceed with
angiography was based on a previously published proto-
col.9 Charts were reviewed for coronary interventions per-
formed, including balloon angioplasty, bare-metal stent
placement, and drug-eluting stent placement. Additionally,
charts were reviewed for periprocedural complications,
including access site and bleeding events, myocardial
infarction, and stroke. Patients were included if information
on both interventions and complications were available.
Patients with a history of CAD and revascularization before
liver transplant workup were excluded.
Based on a starting point selected by a random number
generator, charts were reviewed for the presence of a non−
ECG-gated chest CT performed before coronary angiographyFigure 1. Agatston and Weston calcium scores of left anterior desduring the liver transplant workup. Based on the data from
ECG-gated CT scans in the ESLD population,20 it was
determined that a sample size of 44 patients would be
required to provide 80% power to detect a difference
between those with and without obstructive CAD at an a of
0.05. To account for potential dropout from incomplete
medical records and/or irretrievable CT images, the mini-
mum target sample size was set at 50 patients.
Using VitreaAdvanced (Vital Images Inc., Minnetonka,
Minnesota), CACSs were derived from these non−ECG-
gated CT scans (Figure 1). Agatston scores were calculated
for the left main, left anterior descending, left circumflex,
and right coronary arteries; these scores were subsequently
totaled.11 Absolute scores were then further categorized
based on standard cutoffs that have been proved predictive
of coronary disease.24 Agatston scores were also adjusted
for age and gender, and patients were classified into percen-
tiles using standard protocols based on data generated from
a cohort of over 35,000 patients.25 Additionally, a Weston
score was calculated for each vessel and summed for each
patient (Figure 1).23 Weston scores have been validated
against Agatston scores22 and also account for artifact,23
which is common in non−ECG-gated studies. CACS
results were compared with coronary angiography findings,
with significant stenosis considered ≥50% diameter steno-
sis of at least 1 major coronary artery (Figure 2).
Patients without obstructive coronary disease were com-
pared with those who had obstructive coronary disease oncending (LAD) lesions seen on non−ECG-gated chest CT.
Figure 2. Non−ECG-gated CT coronary calcium versus angiography.
280 The American Journal of Cardiology (www.ajconline.org)baseline characteristics as well as absolute Agatston scores,
Agatston score categories, age-, and gender-adjusted Agat-
ston scores, and Weston scores. The Wilcoxon rank sum
test was used for continuous variables and Fisher’s exact
test was used for categorical variables. Absolute Agatston
scores were log transformed due to skewness.
Based on Agatston scores, a receiver-operating charac-
teristic (ROC) curve was derived and sensitivity, specific-
ity, positive predictive value, and negative predictive value
were calculated. ROC analysis was also repeated using
Weston scores. The area under the curve (AUC) was com-
pared between the Agatston and Weston scores using
DeLong et al’s test.26 The Pearson correlation coefficient
between Agatston scores and Weston scores was calcu-
lated.
Agatston scores were determined by 1 reader (BW) for
all patients. Additionally, a randomly selected subset of 20
patients also had Agatston scores independently determined
by a second reader (BB), to assess inter-reader reliability.
An intraclass correlation coefficient was calculated for
these scores. Additionally, a Bland-Altman plot was created
to compare readers for these 20 patients and a Tukey mean
difference analysis was performed to assess the degree towhich the mean differences between measurements differ
from zero.Results
Nine hundred and fifty-three patients who underwent
coronary angiography as part of their liver transplant
workup from 2006 to 2015 at a single academic medical
center were retrospectively considered. Of these 953
patients, 741 (78%) had intervention and complication data
available. Seventy of 741 patients (9.4%) had at least 1 cor-
onary intervention performed during their liver transplant
workup and 39 of 741 patients (5.3%) had at least 1 compli-
cation as a result of catheterization. The majority of these
complications were bleeding events, which were seen in 23
patients. Twelve patients had periprocedural myocardial
infarctions and 2 patients had periprocedural strokes. Sev-
enteen of the 39 patients who had complications also had
interventions performed.
Review of 308 charts yielded 56 patients who had a non−
ECG-gated chest CT performed before coronary angiogra-
phy. Two of the 56 patients had CT images that could not
be retrieved and were excluded. Statistical power was
Table 1
Comparison of patients who underwent liver transplant workup
Variable Obstructive coronary disease Significance
p value
No Yes
(n = 45) (n = 9)
Age (years) 64 [59.0, 67.5] 67 [53.5, 72.0] 0.59
Female 21 (47%) 3 (33%) 0.72
Hypertension 32 (71%) 6 (67%) 1.00
Hyperlipidemia 8 (18%) 4 (44%) 0.08
Diabetes mellitus 24 (53%) 5 (56%) 1.00
Smoker 15 (33%) 4 (44%) 0.70
Prior coronary
artery disease*
2 (5%) 1 (11%) 0.44
Liver disease etiology:
Alcohol 7 (16%) 2 (22%)
Viral hepatitis 26 (58%) 4 (44%) 0.51
Non-alcoholic
steatohepatitis
5 (11%) 0 (0%)
Other 7 (16%) 3 (33%)
MELD scorey 22.4 [9.73, 32.4] 14.1 [7.9, 29.5] 0.35
Creatininey 1.35 [1.0, 3.1] 1.1 [1.0, 2.5] 0.68
International
normalized ratioy
1.55 [1.2, 2.2] 1.4 [1.0, 2.2] 0.53
Platelet county 50.5 [30.5, 94.5] 84 [46.5, 187] 0.06
Continuous variables were compared with the Wilcoxon rank sum test,
median [interquartile range]. Categorical variables were compared with
Fisher’s exact test, n (%).
* Based on data for n = 52 patients only.
yBased on data for n = 51 patients only.
Table 2
Calcium scores by coronary disease
Obstructive coronary disease Significance
p value
No Yes
(n = 45) (n = 9)
Agatston score 28 [0, 144.5] 311 [144, 1178.5] 0.003
Agatston score positive* 5 (11%) 4 (44%) 0.03
Adjusted Agatston
score positivey
10 (22%) 7 (78%) 0.003
Weston score 2 [0, 5.5] 8 [6, 10] 0.0005
Continuous variables were compared with the Wilcoxon rank sum test,
median [interquartile range]. Categorical variables were compared with
Fisher’s exact test, n (%).
* Positive >400.
y Positive ≥75th percentile for age and gender.
Table 3
Agatston score category by coronary disease
Agatston
Score category
Obstructive coronary disease Significance
p value
No Yes
(n = 45) (n = 9)
0 12 0 0.006*
1-100 18 2
101-400 10 3
>400 5 4
*Comparison through the Wilcoxon rank sum test.
Figure 3. ROC analysis for obstructive coronary disease.
Miscellaneous/Coronary Artery Calcium Preliver Transplant 281achieved with 54 patients included in the final analysis. The
median time between the non−ECG-gated chest CT and
coronary angiography was 26.5 days (interquartile range 7
to 58 days). Nine of these 54 patients with non−ECG-gated
chest CT studies were found to have obstructive CAD; the
other 45 patients did not have obstructive coronary disease.
There were no significant differences in baseline clinical
characteristics between patients with and without obstructive
coronary disease (Table 1). Specifically, these groups did not
differ in regard to age, gender, or cardiovascular risk factors.
Three patients had a history of CAD without previous revas-
cularization. There were no significant differences in groups
with regard to etiology of liver disease or model for ESLD
score. Additionally, there were no significant differences
between groups in baseline INR or platelet counts.
Absolute Agatston scores were significantly higher in
the group with obstructive coronary disease compared with
those without obstructive disease, 311 (144, 1178.5) versus
28 (0, 144.5); p = 0.003 (Table 2). Using a standard cutoff
of 400,24 patients with obstructive coronary disease were
more likely to test positive compared with those without
obstructive disease (44% vs 11%; p = 0.03; Table 2). Simi-
lar results were found for adjusted Agatston scores using a
standard cutoff of ≥75th percentile (Table 2).27 Weston
scores were also significantly higher in the group with
obstructive coronary disease compared with those without
obstructive disease, 8 (6, 10) versus 2 (0, 5.5; Table 2).
Based on standardized categories, Agatston scores were
significantly higher in patients with obstructive coronary
disease compared with those without obstructive disease,
p = 0.006 (Table 3).ROC analysis demonstrated that an Agatston score of
251 maximized sensitivity and specificity for detection of
obstructive coronary disease (Figure 3); using this thresh-
old, sensitivity and specificity were 78% and 87%, respec-
tively. The positive predictive value and negative
predictive value were 54% and 95%, respectively. Only 2
patients (3.7%) with a negative test based on Agatston score
282 The American Journal of Cardiology (www.ajconline.org)<251 had obstructive coronary disease. Additional ROC
analysis demonstrated that an Agatston score of 4 provided
100% sensitivity and a 100% negative predictive value;
using this threshold, 13 patients (24%) could have avoided
catheterization without missing any obstructive coronary
disease.
ROC analysis demonstrated that a Weston score of 6
maximized sensitivity and specificity for detection of
obstructive coronary disease (Figure 3); using this thresh-
old, sensitivity and specificity were 89% and 76%, respec-
tively. The positive predictive value and negative
predictive value were 42% and 97%, respectively. Only 1
patient (1.9%) with a negative test based on Weston score
<6 had obstructive coronary disease. Additional ROC anal-
ysis demonstrated that a Weston score of 2 provided 100%
sensitivity and a 100% negative predictive value; using this
threshold, 15 patients (28%) could have avoided catheteri-
zation without missing any obstructive coronary disease.
ROC analysis showed the AUC for the Agatston score
was 0.82 (95% confidence interval 0.66 to 0.98) and the
AUC for the Weston score was 0.86 (95% confidence inter-
val 0.74 to 0.99; Figure 3); this difference was not statisti-
cally significant (p = 0.256). It should be noted that the
Weston score did have a slightly higher AUC compared
with the Agatston score, suggesting a trend toward better
performance in identifying obstructive coronary disease in
this population.
There was a strong, positive correlation between Agat-
ston scores and Weston scores for all patients (r = 0.93;
Figure 4). There was a positive correlation for AgatstonFigure 4. Agatston score vscores between both readers (intraclass correlation coeffi-
cient = 0.98). Additionally, by Bland-Altman analysis, there
was no significant difference between readers in terms of
Agatston scores (p = 0.38).Discussion
This study demonstrated the predictive value of inciden-
tal coronary artery calcium discovered on non−ECG-gated
CT in patients who underwent preoperative evaluation for
liver transplant. It also demonstrated that Agatston scores
can be applied to non−ECG-gated studies in this popula-
tion. Additionally, this study showed that Weston scores
approximated Agatston scores in predicting obstructive cor-
onary disease. Our results suggest that coronary calcium
scoring may be an important addition to the risk stratifica-
tion of liver transplant candidates.
The most recent recommendations from the American
Heart Association and the American College of Cardiology
Foundation suggest noninvasive stress testing based on car-
diovascular risk factor assessment for patients without
active cardiac disease.4 However, guidelines from the
American Association for the Study of Liver Diseases and
the American Society of Transplantation recommend non-
invasive cardiac testing for all adults who underwent liver
transplant workup.5 Alternatively, many cardiologists advo-
cate for invasive angiography in patients with more than
2 cardiac risk factors before listing for OLT.6
Data on cardiac catheterization in ESLD patients raise
concerns about safety. Studies have demonstrated higherersus Weston score.
Miscellaneous/Coronary Artery Calcium Preliver Transplant 283rates of complications, such as major bleeding and pseudoa-
neurysm formation, in patients with liver failure compared
with control patients who underwent left heart catheteriza-
tion.8 Additionally, the interventional cardiology commu-
nity recommends the use of special considerations in these
patients, such as prophylactic platelet and/or fresh frozen
plasma transfusions as well as smaller vascular sheaths.7
In our subgroup of 741 patients with catheterization out-
comes data, 22 of 671 (3.3%) who underwent diagnostic
angiography and 17 of 70 (24.3%) who had interventions
performed experienced complications. These figures are
higher than average for all patients who undergo diagnostic
and interventional cardiac catheterization, respectively.28,29
Although the majority of the complications seen in our popu-
lation were bleeding events (59% of patient complications),
which may be regarded as relatively benign, treatment can
be complex in liver transplant candidates due to underlying
thrombocytopenia and coagulopathy.
To avoid potential complications, liver transplant teams
have turned to pharmacologic stress testing in OLT candi-
dates. In 1 study of 389 patients who underwent preopera-
tive evaluation before OLT, dobutamine stress
echocardiogram (DSE), and single photon emission com-
puted tomography (SPECT) had sensitivities of 9% and
57%, respectively, for perioperative cardiac events.2 Simi-
lar results were seen in a larger (n = 473) study, which
focused on the use of SPECT imaging in the preliver trans-
plant evaluation: we demonstrated a sensitivity of only
62% for adenosine and 35% for regadenoson SPECT, in
diagnosing severe CAD and concluded that SPECT was a
poor screening test in the pre-OLT population.9
Two studies have demonstrated relations between ECG-
gated CT scans and cardiac catheterization findings in OLT
candidates.19,20 These studies used only Agatston scores to
evaluate patients and were limited in terms of sample size.
Data from coronary CT angiography have shown a prog-
nostic value similar to DSE and carry the additional risk of
contrast dye.10 In addition, CT angiography needs to be
gated and can be difficult to obtain in ESLD patients who
are often tachycardic. The ability to use non−ECG-gated
CT exams would facilitate obtaining important noninvasive
information about CAD in the ESLD population.
Our data confirm the strength of calcium scoring in rul-
ing out coronary disease in patients being evaluated for
OLT. By lowering the threshold for considering a patient to
be positive to an Agatston score of 4 or a Weston score of
2, we predicted nonobstructive coronary disease with 100%
certainty in our population. This would have prevented 13
(24%) or 15 (28%) catheterizations, based on Agatston or
Weston scores, respectively. Using this calcium screen
threshold could thereby prevent complications from inva-
sive angiography.
Many liver transplant candidates undergo nongated,
noncontrast chest CT during their workup. We found that
56 of the 308 patients (18.1%) randomly reviewed for this
study had a nongated chest CT ordered within 6 months of
angiography. The most common reason for this was staging
for hepatocellular carcinoma (HCC). However, other rea-
sons included history of obstructive or parenchymal pulmo-
nary disease, screening for lung cancer, concern for
pulmonary infection, evaluation for pulmonaryhypertension, or arteriovenous shunt, and to follow up
abnormalities on chest x-ray or pulmonary function testing.
A limitation of this study includes the potential bias regard-
ing CAD risk introduced by the subgroup of transplant can-
didates who underwent chest CT. Limited data suggest
similar rates of mild-to-moderate CAD and preoperative
revascularization in liver transplant candidates with HCC
versus those without HCC.30
Other limitations of this study include its retrospective
nature and the biases inherent in this design. The associa-
tions we found are only hypothesis generating and suggest
a need for randomized, prospective studies in the future.
Additionally, this study was relatively limited in terms of
sample size analyzed due to the retrospective nature of the
design and frequency with which nongated CT was per-
formed during the precatheterization time interval. Fortu-
nately, the sample size obtained did fulfill our power
requirement and demonstrated a significant difference in
coronary calcium between ESLD patients with and without
obstructive CAD.
Another specific limitation involves the interpretation of
nongated CT using criteria designed for gated studies. The
chest imaging obtained in this study was for noncardiac
purposes and not part of a protocol for cardiac risk stratifi-
cation, and thus it is difficult to estimate the true prevalence
of coronary calcification in OLT candidates. Moreover,
many of the images did contain motion artifact, which can
falsely elevate the Agatston score. A strength of this study
was also including the semiquantitative Weston score,
which is less subject to motion artifact; this may be 1 of the
reasons that the Weston score outperformed the Agatston
score in our study. Additional data are needed comparing
these scores in non−ECG-gated studies.
Future studies should evaluate whether the addition of a
calcium score impacts the preoperative evaluation of liver
transplant candidates. The Agatston and Weston score cut-
offs established in this study can be used to prospectively
risk stratify patients for angiography. Ultimately, calcium
scoring may be integrated into preoperative algorithms to
rule out obstructive disease and help to avoid invasive angi-
ography in this high-risk population.
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